You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
IGHA2
Immunoglobulin heavy constant alpha 2

Protein Summary
Description
Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:22158414, PubMed:20176268). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affin ...more
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000390539
  • ENSP00000374981
  • ENSG00000211890
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
tissue sample
0.6
tissue
0.56
cellular component
0.43
disease
0.37
drug
0.35


Related Tools
GENEVA
GENEVA (GENe Expression Variance Analysis) allows you to identify RNA-sequencing datasets from the Gene Expression Omnibus (GEO) that contain conditions modulating a gene or a gene signature.
GlyGen
GlyGen is a data integration and dissemination project for carbohydrate and glycoconjugate related data.
ARCHS4
ARCHS4 provides access to gene-function predictions based on RNA-seq co-expression, and gene expression levels across cell and tissues.
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 0   (req: < 5)
Gene RIFs: 1   (req: <= 3)
Antibodies: 0   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 0   (req: >= 5)
Gene RIFs: 1   (req: > 3)
Antibodies: 0   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 16
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0
Protein Structure (1 Structure, 1 AlphaFold Model)
RepresentationColor Scheme

Click on a row in the table to change the structure displayed.
More information can be found at RCSB PDB

AF-P01877-F1-model_v1

AlphaFold Structures Developed by DeepMind and EMBL-EBI

1 – 1 of 1
PDB Structure Id
Ligand
Method
Resolution (Å)
Residues
Fraction of Total Protein
Pub Year
Title
PDB Structure Id
Fraction of Total Protein
Resolution
Pub Year
Pathways (5)
Binding and Uptake of Ligands by Scavenger Receptors (R-HSA-2173782)

Click on a row in the table to change the structure displayed.

Items per page:
1 – 5 of 5
Data Source
Name
Explore in Pharos
Explore in Source
Reactome
Binding and Uptake of Ligands by Scavenger Receptors
Reactome
Cell surface interactions at the vascular wall
Reactome
Hemostasis
Reactome
Scavenging of heme from plasma
Reactome
Vesicle-mediated transport
Name
Explore in Pharos
Explore in Source
Binding and Uptake of Ligands by Scavenger Receptors
Cell surface interactions at the vascular wall
Hemostasis
Scavenging of heme from plasma
Vesicle-mediated transport
Gene Ontology Terms (25)
Items per page:
10
1 – 2 of 2
GO Term
Evidence
Assigned by
Inferred from Biological aspect of Ancestor (IBA)
GO_Central
Inferred from Biological aspect of Ancestor (IBA)
GO_Central
Protein-Protein Interactions (33)
1 – 10 of 33
DDX31
Tbio
Family: Enzyme
Novelty: 2.84646195
p_int: 0.999998429
p_ni: 0.000001503
p_wrong: 6.8e-8
Data Source: BioPlex
FRMD1
Tdark
Novelty: 0.96833141
p_int: 0.999996004
p_ni: 0.000003995
p_wrong: 2e-9
Data Source: BioPlex
SNX27
Tbio
Novelty: 0.02419724
p_int: 0.999984382
p_ni: 0.000015618
Data Source: BioPlex
ZNF491
Tdark
Family: TF
Novelty: 4.75862069
p_int: 0.999955661
p_ni: 0.000043943
p_wrong: 3.95e-7
Data Source: BioPlex
HBM
Tdark
Novelty: 0.02658671
p_int: 0.999874717
p_ni: 0.000124979
p_wrong: 3.04e-7
Data Source: BioPlex
UQCRQ
Tbio
Novelty: 0.04392627
p_int: 0.999792505
p_ni: 0.000207478
p_wrong: 1.7e-8
Data Source: BioPlex
TMEM237
Tdark
Novelty: 0.27005874
p_int: 0.999787782
p_ni: 0.000209517
p_wrong: 0.000002701
Data Source: BioPlex
PCK2
Tbio
Family: Kinase
Novelty: 0.0035563
p_int: 0.999710039
p_ni: 0.000289914
p_wrong: 4.7e-8
Data Source: BioPlex
ITPRID2
Tbio
Novelty: 0.07923791
p_int: 0.999661822
p_ni: 0.000328166
p_wrong: 0.000010012
Data Source: BioPlex
SNW1
Tbio
Novelty: 0.01423797
p_int: 0.999580315
p_ni: 0.000419552
p_wrong: 1.34e-7
Data Source: BioPlex
Publication Statistics
PubTator Score  5.28

PubTator score by year
Amino Acid Sequence
Residue Counts
Protein Sequence
ProtVista Viewer